| Mar 31, 2025 |
Apr 1, 2025 |
Perspective Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+23,475
|
14.25%
|
✗
|
$50K |
| Jun 14, 2024 |
Jun 18, 2024 |
Perspective Therapeutics, Inc.
|
Director |
Buy |
83.8
|
+4,587
|
2.86%
|
✗
|
$50K |
| Jun 3, 2024 |
Jun 4, 2024 |
Perspective Therapeutics, Inc.
|
Director |
Buy |
78.8
|
+34,246
|
2.25%
|
✗
|
$50K |
| Dec 14, 2023 |
Dec 18, 2023 |
Perspective Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+185,200
|
13.39%
|
✗
|
$50K |
| Nov 15, 2022 |
Nov 17, 2022 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+100,000
|
9.13%
|
✗
|
$33.5K |
| Jun 7, 2022 |
Jun 9, 2022 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+75,000
|
7.35%
|
✗
|
$22.2K |
| Nov 30, 2020 |
Dec 2, 2020 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+68,000
|
11.51%
|
✗
|
$25.5K |
| Oct 22, 2020 |
Oct 28, 2020 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+48,076
|
8.86%
|
✗
|
$25K |
| Nov 14, 2019 |
Nov 19, 2019 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
95.0
|
+150,000
|
115.38%
|
✗
|
$59.3K |
| Nov 14, 2018 |
Nov 15, 2018 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
95.0
|
+130,000
|
100.00%
|
✗
|
$51.7K |
| May 19, 2008 |
May 21, 2008 |
Perspective Therapeutics, Inc.
|
COO |
Buy |
90.0
|
+5,000
|
166.67%
|
✗
|
$4.5K |